The role of heart failure pharmacotherapy after left ventricular assist device support.

Published

Journal Article (Review)

Left ventricular assist devices (LVADs) are an increasingly common treatment for end-stage systolic heart failure. However, there are limited data on how to best treat patients pharmacologically after LVAD implantation, resulting in uncertainty about which heart failure medications provide the most benefit. Still, some evidence exists that certain medical therapies can prevent remodeling and improve right ventricular and, possibly, left ventricular function. This article reviews the current literature for medical heart failure therapy in LVAD patients, and possible future treatment strategies.

Full Text

Duke Authors

Cited Authors

  • Rommel, JJ; O'Neill, TJ; Lishmanov, A; Katz, JN; Chang, PP

Published Date

  • October 2014

Published In

Volume / Issue

  • 10 / 4

Start / End Page

  • 653 - 660

PubMed ID

  • 25217439

Pubmed Central ID

  • 25217439

International Standard Serial Number (ISSN)

  • 1551-7136

Digital Object Identifier (DOI)

  • 10.1016/j.hfc.2014.07.008

Language

  • eng

Conference Location

  • United States